Resurfacing Marico's August update: Q1 FY26 revenue rose 23%, profit up 8% on India growth

Marico had reported (in early August) Q1 FY26 consolidated revenue of ₹3,259 crore, up 23.3% year on year, while net profit rose 8.2% to ₹513 crore. India revenue grew 27.2% to ₹2,495 crore and international revenue increased 12.9%; the company also raised its stake in Plix maker Satiya Nutraceuticals to 60%.

— FiledThu, 17 Sept, 2026, 18:04 IST·First seen Thu, 17 Sept, 2026, 18:04 IST·Source Financial Express (via Wayback)

What happened

Marico reported Q1 FY26 profit growth of 8.2% and revenue growth of 23.3%, led by a 27.2% rise in India revenue. It cited near-double-digit underlying India

Key facts

  • Q1 FY26 consolidated net profit rose 8.2% YoY to Rs 513 crore from Rs 474 crore
  • Revenue from operations rose 23.31% to Rs 3,259 crore from Rs 2,643 crore
  • Total income was Rs 3,315 crore, including Rs 56 crore other income
  • Total expenses increased to Rs 2,659 crore from Rs 2,075 crore
  • India revenue rose 27.17% to Rs 2,495 crore from Rs 1,962 crore
  • International revenue grew 12.91% to Rs 764 crore from Rs 681 crore
  • India segment PBT was Rs 469 crore; international segment PBT was Rs 213 crore
  • Marico increased its Satiya Nutraceuticals stake to 60% on a fully diluted basis

Why this matters

Increasing its stake in Plix maker Satiya Nutraceuticals to 60% strengthens Marico’s exposure to the high-growth nutrition and wellness category alongside its core FMCG portfolio.

What to watch

  • Sequential India volume growth versus price-led growth.
  • Gross-margin and EBITDA-margin movement relative to the slower net-profit growth rate.
  • Copra, edible-oil, packaging and currency trends that could affect input costs.
  • Advertising-and-promotion spend as a share of sales.
  • Plix revenue growth, D2C acquisition economics, offline expansion and integration-related costs.
  • International revenue acceleration or deceleration, especially amid local-currency and geopolitical volatility.
  • Increase advertising and trade activation behind India growth categories while protecting core-brand availability.
  • Use expanded control of Plix to widen omnichannel distribution, bundle wellness products and scale cross-selling through Marico's retail network.
  • Pursue selective price-pack architecture and premium SKUs to offset commodity volatility without weakening volume momentum.
  • Focus investor communication on margin trajectory, India volume growth and the profit contribution from international and acquired businesses.